LARIMAR THERAPEUTICS
LRMR Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-13
2025-05-14
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$175.44M
2025-01-22
2025-01-24
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
205K
$0.00
1
$175.44M
2025-01-22
2025-01-24
CELANO MICHAEL
Chief Financial Officer
A - Grant
Common Stock
34,185
$0.00
1
$175.44M
2025-01-22
2025-01-24
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$175.44M
2025-01-22
2025-01-24
SHANKAR GOPI
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$175.44M
2025-01-22
2025-01-24
SHANKAR GOPI
Chief Development Officer
A - Grant
Common Stock
23,306
$0.00
1
$175.44M
2025-01-22
2025-01-24
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$175.44M
2025-01-22
2025-01-24
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Common Stock
23,306
$0.00
1
$175.44M
2025-01-22
2025-01-24
SHANKAR GOPI
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$175.44M
2025-01-22
2025-01-24
SHANKAR GOPI
Chief Development Officer
A - Grant
Common Stock
23,306
$0.00
1
$175.44M
2025-01-22
2025-01-24
CELANO MICHAEL
Chief Financial Officer
A - Grant
Common Stock
34,185
$0.00
1
$175.44M
2025-01-22
2025-01-24
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
546K
$0.00
1
$175.44M
2025-01-22
2025-01-24
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Common Stock
23,306
$0.00
1
$175.44M
2025-01-22
2025-01-24
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
546K
$0.00
1
$175.44M
2025-01-22
2025-01-24
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
205K
$0.00
1
$175.44M
2024-05-29
2024-05-31
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$175.44M
2024-01-17
2024-01-19
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
397K
$0.00
1
$175.44M
2024-01-17
2024-01-19
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
188K
$0.00
1
$175.44M
2024-01-17
2024-01-19
CELANO MICHAEL
Chief Financial Officer
A - Grant
Common Stock
31,250
$0.00
1
$175.44M
2024-01-17
2024-01-19
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$175.44M
2024-01-17
2024-01-19
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Common Stock
22,500
$0.00
1
$175.44M
2024-01-17
2024-01-19
SHANKAR GOPI
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$175.44M
2024-01-17
2024-01-19
SHANKAR GOPI
Chief Development Officer
A - Grant
Common Stock
22,500
$0.00
1
$175.44M
2023-12-07
2023-12-08
SHANKAR GOPI
Chief Development Officer
P - Purchase
Common Stock
5,000
$4.00
20,000
1
$175.44M
2023-07-17
2023-07-18
CLAYTON RUSSELL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
180K
$0.00
1
$175.44M
2023-05-17
2023-05-18
BEN-MAIMON CAROLE
President and CEO
P - Purchase
Common Stock
5,000
$4.00
20,000
1
$175.44M
2023-05-17
2023-05-18
CELANO MICHAEL
Chief Financial Officer
P - Purchase
Common Stock
5,000
$4.00
20,000
1
$175.44M
2023-05-09
2023-05-11
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (Right to Buy)
8,300
$0.00
1
$175.44M
2023-02-07
2023-02-09
SHANKAR GOPI
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
180K
$0.00
1
$175.44M
2023-01-31
2023-02-02
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
325K
$0.00
1
$175.44M
2023-01-31
2023-02-02
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$175.44M
2023-01-31
2023-02-02
CELANO MICHAEL
Chief Financial Officer
A - Grant
Common Stock
76,000
$0.00
1
$175.44M
2022-09-16
2022-09-19
BEN-MAIMON CAROLE
President and CEO
P - Purchase
Common Stock
31,746
$3.00
95,238
1
$175.44M
2022-09-16
2022-09-19
CELANO MICHAEL
Chief Financial Officer
P - Purchase
Common Stock
31,746
$3.00
95,238
1
$175.44M
2022-05-10
2022-05-12
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$175.44M
2022-05-10
2022-05-12
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$175.44M
2022-05-10
2022-05-12
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (Right to Buy)
8,300
$0.00
1
$175.44M
2022-01-18
2022-01-20
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
182K
$0.00
1
$175.44M
2022-01-18
2022-01-20
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$175.44M
2021-05-12
2021-05-17
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (right to buy)
8,300
$0.00
1
$175.44M
2021-01-19
2021-01-21
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (Right to Buy)
107K
$0.00
1
$175.44M
2021-01-19
2021-01-21
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
42,000
$0.00
1
$175.44M
2020-09-29
2020-09-30
BEN-MAIMON CAROLE
President and CEO
A - Grant
Stock Option (right to buy)
411K
$0.00
1
$175.44M
2020-09-29
2020-09-30
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (right to buy)
84,100
$0.00
1
$175.44M
2020-09-29
2020-09-30
HAMILTON THOMAS EDWARD
A - Grant
Stock Option (right to buy)
16,600
$0.00
1
$175.44M
2020-06-26
2020-06-30
CHONDRIAL THERAPEUTICS HOLDINGS, LLC
J - Other
Common Stock
-6.09M
$0.00
1
$175.44M
2020-05-28
2020-06-05
CELANO MICHAEL
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
60,479
$0.00
1
$175.44M